Moleculin Biotech, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Moleculin Biotech, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2025.
  • Moleculin Biotech, Inc. Operating Lease, Payments for the quarter ending June 30, 2025 was $39K, a 2.63% increase year-over-year.
  • Moleculin Biotech, Inc. Operating Lease, Payments for the twelve months ending June 30, 2025 was $157K, a 25.6% increase year-over-year.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2024 was $146K, a 8.96% increase from 2023.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2023 was $134K, a 3.88% increase from 2022.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2022 was $129K, a 6.52% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $157K $39K +$1K +2.63% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $156K $39K +$10K +34.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $146K $40K +$16K +66.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-21
Q3 2024 $130K $39K +$5K +14.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $125K $38K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $125K $29K -$9K -23.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $134K $24K -$14K -36.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-21
Q3 2023 $148K $34K +$13K +61.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $135K $38K +$3K +8.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $132K $38K +$3K +8.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $129K $38K +$3K +8.57% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $126K $21K -$14K -40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $140K $35K +$1K +2.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $139K $35K +$1K +2.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $138K $35K +$1K +2.94% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $137K $35K +$1K +2.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $136K $34K +$1K +3.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $135K $34K +$1K +3.03% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $134K $34K +$1K +3.03% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $133K $34K +$14K +70% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $119K $33K +$20K +154% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $99K $33K +$25K +313% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $74K $33K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 $20K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $13K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $8K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.